uBriGene（Boston）Biosciences

uBriGene (Boston) Biosciences is committed to providing one-stop CDMO services for cell and gene therapy. The company has established an integrated innovative biopharmaceutical CDMO platform, offering GMP-grade plasmid preparation, viral packaging, and T-cell production services for CAR-T manufacturing, supporting from preclinical to clinical and commercial stages. Additionally, the company provides viral vectors, including adeno-associated virus and lentivirus vectors, to meet the needs of research or manufacturing applications.